
Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment.

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment.

Dr. Christina Cho explains that a strong transplant program provides advanced treatments along with a supportive team for patients with blood cancers.

LiveLung announced the launch of its new Chaplain Program.

This Prostate Cancer Awareness Month, join our free Men's Health Event.

Going through breast cancer has pushed me to do things I never thought I would.

This Prostate Cancer Awareness Month, a first-in-the-nation trial offers hope by using a targeted therapy before surgery to stop recurrence in its tracks.

CURE spoke with Amanda Davis at the John Theurer Cancer Center in Hackensack, New Jersey.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United.

Tecvayli and Darzalex demonstrated meaningful clinical efficacy in transplant-eligible patients with newly diagnosed multiple myeloma.

Dr. Prithviraj Bose discussed the current treatment landscape for myeloproliferative neoplasms, a group of rare blood cancers; he focused on myelofibrosis.

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, avoiding unnecessary surgery.

Patients need long-term monitoring after gastrointestinal stromal tumor surgery, with some requiring extra treatment or genetic testing to lower recurrence risk.

Dr. Ravi Munver sat down for an interview with CURE to discuss progress in kidney cancer care.

I was diagnosed with colon cancer at 17, and while I’ll always be part of the AYA community, turning 40 has shown me the gift of growing older.

CURE spoke with nurse and breast cancer survivor Amanda Davis at the John Theurer Cancer Center.

Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer.

Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team.

Learn how myelodysplastic syndrome treatment has advanced with targeted therapies and anemia management while balancing quality of life for patients.

After receiving a breast cancer diagnosis at 29, Amanda Davis wants other young adults who are patients to know that “brighter days are coming.”

It is very important to let the world know that no matter how healthy you think you are, if you have lungs, you can potentially develop lung cancer.

Kidney cancer care has seen advances over the past few decades, reflecting both improved diagnostic capabilities and less invasive treatment approaches.

The U.S. FDA has granted fast track designation to the investigational therapy MNV-201 for the treatment of myelodysplastic syndrome.

Non-melanoma skin cancer is a common and highly treatable type of cancer that originates in the top layer of the skin, like basal cell carcinoma.

The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.

Many of the choices I've made regarding yard maintenance relate to my hopes to mitigate the risk of more cancer.

A guide for patients to understand HER2-positive breast cancer, treatment options by stage and how to talk with your oncologist.

Among patients with pancreatic cancer, the vaccine ELI-002 7P elicited strong mKRAS-specific T cell responses in approximately 99% of patients.

Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox Chase Cancer Center.

A cancer survivor explains that we must all become involved in trying to bring back cancer research.

Nancee Pronsati discusses a new patient-authored guide for managing ALK-directed treatment side effects in lung cancer and improving quality of life.